Pantelis Vlachos

<scp>AURIEL</scp> ‐PsO: a randomized, double‐blind phase <scp>III</scp> equivalence trial to demonstrate the clinical similarity of the proposed biosimilar <scp>MSB</scp> 11022 to reference adalimumab in patients with moderate‐to‐severe chronic plaque‐type psoriasis

Jana Hercogová, Kim Papp, V. Chyrok et al. · British Journal of Dermatology · 2019 · 63 citations · Full text

A simulation-intensive approach for checking hierarchical models

Dipak K. Dey, Alan E. Gelfand, Tim B. Swartz et al. · Test · 1998 · 58 citations

Engineering, Automated Reasoning, Verification +10

Comparison of the pharmacokinetics, safety, and immunogenicity of MSB11022, a biosimilar of adalimumab, with Humira^® in healthy subjects

Elizabeth Hyland, Tim Mant, Pantelis Vlachos et al. · British Journal of Clinical Pharmacology · 2016 · 48 citations · Full text

Detecting Collaborations in Text Comparing the Authors' Rhetorical Language Choices in The Federalist Papers

Jeff Collins, David S. Kaufer, Pantelis Vlachos et al. · Computers and the Humanities · 2003 · 45 citations

Text Comparing, Engineering, Argumentation Analysis +16

Safety of adalimumab biosimilar MSB11022 (acetate-buffered formulation) in patients with moderately-to-severely active rheumatoid arthritis

Christopher J Edwards, Joëlle Monnet, Martin Ullmann et al. · Clinical Rheumatology · 2019 · 30 citations · Full text